Wegovy and Your Gallbladder: Understanding the Risk

Gallbladder problems, including gallstones and cholecystitis, are listed as known side effects in the Wegovy patient information leaflet.
Severe upper-right abdominal pain, fever, nausea, or jaundice after starting Wegovy should be assessed by a doctor promptly, do not wait for a scheduled review.
Rapid weight loss accelerates gallstone formation by increasing the cholesterol concentration in bile; semaglutide also slows gallbladder emptying, which compounds this effect.
Having had your gallbladder removed does not automatically rule out Wegovy, but it changes the risk picture, discuss your history with a prescriber before starting.

Gallbladder problems are a recognised side effect of Wegovy (semaglutide). Rapid weight loss of any kind — including weight loss driven by a GLP-1 medicine — raises the risk of gallstones forming, and some people on semaglutide develop gallbladder inflammation or need surgery. That risk is real, but it is manageable and, for most people, does not make Wegovy unsuitable. The key is knowing what to watch for and when to act. These are prescription-only medicines, and the decision about whether they are right for you rests with a clinical assessment, not a self-check.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Making an Informed Decision About Wegovy When Gallbladder Risk Is on Your Mind

Why weight-loss medicines and gallbladder trouble are connected

The gallbladder stores bile, which the body uses to digest fat. When you lose weight quickly, your liver releases more cholesterol into bile than the gallbladder can effectively process, and that excess cholesterol can crystallise into gallstones. This happens with any form of rapid weight loss, very low-calorie diets, bariatric surgery and GLP-1 medicines all carry the same underlying mechanism.

Semaglutide adds a second layer. As a GLP-1 receptor agonist, it slows gastric emptying and reduces appetite, but it also reduces the frequency with which the gallbladder contracts to release bile. A gallbladder that sits idle for longer periods accumulates more concentrated bile, which makes stone formation more likely. The NHS medicines page for semaglutide lists cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) as known side effects of Wegovy. The SmPC on the electronic Medicines Compendium gives the detailed frequency data for anyone who wants to read the clinical labelling in full.

This does not mean Wegovy causes gallbladder problems in most people who take it. The absolute risk remains low in absolute terms, and for many patients the benefits of sustained weight reduction outweigh this particular risk. The decision, though, should never be made in a vacuum. You can read a broader overview of Wegovy's side-effect profile if you want to see where gallbladder symptoms fit in the full picture.

What gallbladder symptoms actually feel like during treatment

A question our prescribers hear most weeks is some version of: "I have pain on my right side, is that the Wegovy?" It is worth being specific about what gallbladder symptoms typically involve, because upper-GI discomfort from semaglutide is common and usually benign, while gallbladder pain is a different animal.

Gallstone pain tends to be sharp or cramping rather than the dull nausea of GI adjustment. It often sits in the upper-right abdomen, below the ribs, and can radiate to the right shoulder blade. It typically comes on within a few hours of eating a fatty meal, because that is when the gallbladder is asked to contract. Cholecystitis (inflammation, usually when a stone blocks the bile duct) brings more persistent pain, fever, and sometimes vomiting that does not settle.

General GI side effects of Wegovy, by contrast, tend to be nausea-led, more diffuse, and most noticeable in the days after starting or increasing the dose, often fading over a week or two. If you are unsure which category your symptoms fall into, that uncertainty is itself a reason to contact a clinician. You can find more detail on the gastrointestinal side-effect pattern, including loose stools that some people experience, in our dedicated side-effects resources.

When to get medical help, and what to report

Some symptoms during Wegovy treatment need prompt attention rather than a "wait and see" approach. Contact a doctor or attend urgent care if you develop:

Severe or persistent pain in your upper-right abdomen or back that does not ease within a couple of hours; fever alongside abdominal pain; yellowing of the skin or whites of the eyes (jaundice); very dark urine or pale stools, which can indicate bile duct obstruction; or vomiting that prevents you from keeping fluids down alongside any of the above.

These symptoms point to possible gallbladder obstruction or inflammation. Left untreated, cholecystitis can become a surgical emergency, so seeking help quickly matters. The MHRA's Yellow Card scheme lets you report any suspected side effect from a medicine, including gallbladder problems linked to semaglutide. Reporting helps regulators build a clearer picture of real-world safety data, and it takes only a few minutes.

The specific situation of patients without a gallbladder

Some people considering Wegovy have already had their gallbladder removed, usually because of previous gallstone disease. The question of whether semaglutide is appropriate in this situation is not straightforward, and the honest answer is that it depends on your individual history and health picture.

Without a gallbladder, bile flows directly from the liver into the small intestine continuously rather than being stored and released in response to meals. Some people without a gallbladder experience looser stools or difficulty digesting fatty foods; adding a medicine that also affects GI motility can intensify this. On the other hand, if you are wondering whether semaglutide is safe to use when you have no gallbladder, the specific risk of acute cholecystitis does at least disappear once the gallbladder is gone. Our pages on taking Wegovy without a gallbladder, on semaglutide after gallbladder removal, and on whether semaglutide is suitable without a gallbladder cover the clinical picture in more depth.

At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber who will ask about your surgical history and factor it into their assessment. If you have questions before you start, our clinical team is also available through aftercare seven days a week. You can speak to our prescribers about suitability and discuss any gallbladder concerns as part of your free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions